Aeterna Zentaris Inc (NASDAQ:AEZS)
CAPS Rating:
A growing global biopharmaceutical company focused on endrocrine therapy and oncology, in drug discovery, development and commercialization.
A growing global biopharmaceutical company focused on endrocrine therapy and oncology, in drug discovery, development and commercialization.
Recs
Uhhhh............ it will just do bad. :) --A Scientist
well that's convincing.
ENIGMA, NOT THAT IT MATTERS BUT HAS ANYONE POINTED OUT TO YOU THE POST YOU JUST COMMENTED ON IS 4 YRS OLD
YOU MUST STILL BE ON PHONE LINE INTERNET, OR REALLY TAKE YOUR DD TO THE NEXT LEVEL OF RESEARCH